6/17/2022 1:02:03 PM - Met resistance near its 200 DMA line and it has been sputtering since the 5/10/22 mid-day report last noted - <i>"Reported Mar &#39;22 quarterly earnings +22% on +15% sales revenues versus the year ago period. Prior quarterly comparisons have not shown strong and steady earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong."</i><br><hr>5/10/2022 1:41:14 PM - Rebounding near its 200 DMA line. The 2/04/22 mid-day report noted - <i>"Reported Mar &#39;22 quarterly earnings +22% on +15% sales revenues versus the year ago period. Prior quarterly comparisons have not shown strong and steady earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong."</i><br><hr>2/4/2022 12:50:51 PM - Rallied after testing its 200 DMA line this week. Reported Dec &#39;21 quarterly earnings +22% on +15% sales revenues versus the year ago period. Prior quarterly comparisons have not shown strong and steady earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.<br><hr>2/2/2022 12:39:20 PM - Testing its 200 DMA line ($55.29). Due to report Dec &#39;21 quarterly earnings results. The 3 prior quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.<br><hr>4/12/2016 12:31:12 PM - Recently wedging into new high territory with gains lacking great volume conviction. Reported Dec &#39;15 earnings +10% on +1% sales revenues, a 2nd consecutive quarter with earnings below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong.<br><hr>2/4/2016 12:38:18 PM - Reported stronger than expected Dec &#39;15 earnings and rallied above its 50 DMA line with a considerable volume-driven gain today, rebounding from below its 200 DMA line. Earnings rose +20% on +14% sales revenues for the Sep &#39;15 quarter, a fundamental flaw after 3 consecutive quarters with earnings above the +25% minimum guideline (C criteria). Its annual earnings (<strong>A</strong> criteria) history has been strong.<br><hr>11/30/2015 1:23:19 PM - Pulling back today with heavy volume testing its 50 DMA line. Reported earnings +20% on +14% sales revenues for the Sep &#39;15 quarter, a fundamental flaw after 3 consecutive quarters with earnings above the +25% minimum guideline (C criteria). Its annual earnings (<strong>A</strong> criteria) history has been strong.<br><hr>9/3/2015 12:44:50 PM - Violated its 50 DMA line with damaging volume-driven losses and it has not formed a sound base. Stalled and endured distributional pressure after last noted in the 8/14/15 mid-day report - <em>&quot;Reported earnings +27% on +32% sales revenues for the Jun &#39;15 quarter, its 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system&#39;s winning models. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot; </em><br><hr>8/14/2015 1:27:22 PM - Patient investors may watch for a new base to possibly form and be noted in the weeks ahead. Held its ground stubbornly and touched a new 52-week high today&#39;s gain backed by above average volume. Found support at its 50 DMA line, but it is extended from any sound base. Reported earnings +27% on +32% sales revenues for the Jun &#39;15 quarter, its 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system&#39;s winning models. Its annual earnings (<strong>A</strong> criteria) history has been strong.<br><hr>8/6/2015 1:05:51 PM - Reported earnings +27% on +32% sales revenues for the Jun &#39;15 quarter, its 3rd consecutive quarter with earnings above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system&#39;s winning models. Its annual earnings (<strong>A</strong> criteria) history has been strong.<em>&nbsp;</em>Touched a new 52-week high with today&#39;s gain backed by above average volume. Found support at its 50 DMA line, but it is extended from any sound base.   Patient investors may watch for a new base to possibly form and be noted in the weeks ahead.<br><hr>7/31/2015 1:16:00 PM - Challenging its 52-week high with today&#39;s gain. Found support at its 50 DMA line and made gradual progress since last noted with caution in the 5/14/15 mid-day report - <em>&quot;Reported +34% earnings on +33% sales revenues for the Mar &#39;15 quarter, its 2nd quarter with earnings above the +25% minimum guideline (C criteria).  Prior comparisons had sub par sales revenues growth and earnings. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot;  </em><br><hr>5/14/2015 1:49:16 PM - Challenging its 52-week high with today&#39;s big volume-driven gain. Reported +34% earnings on +33% sales revenues for the Mar &#39;15 quarter, its 2nd quarter with earnings above the +25% minimum guideline (C criteria).  Prior comparisons had sub par sales revenues growth and earnings. Its annual earnings (<strong>A</strong> criteria) history has been strong.<br><hr>4/9/2015 1:03:58 PM - Hitting a new 52-week high today while adding to a recent spurt of volume-driven gains. Prior mid-day reports cautioned - <em>&quot;Reported <strong>+60%</strong> earnings on <strong>+36%</strong> sales revenues for the Dec &#39;14 quarter. Prior quarters were below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) with sub par sales revenues growth. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot; </em><br><hr>3/27/2015 12:36:43 PM - Perched near its 52-week high, encountering distributional pressure this week after a spurt of gains. Held its ground near prior highs and above its 50 DMA line since noted with caution in the 2/10/15 mid-day report - <em>&quot;Reported <strong>+60%</strong> earnings on <strong>+36%</strong> sales revenues for the Dec &#39;14 quarter. Prior quarters were below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) with sub par sales revenues growth. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot; </em><br><hr>3/25/2015 12:45:16 PM - Perched at its 52-week high after a spurt of gains. Held its ground near prior highs and above its 50 DMA line since noted with caution in the 2/10/15 mid-day report - <em>&quot;Reported <strong>+60%</strong> earnings on <strong>+36%</strong> sales revenues for the Dec &#39;14 quarter. Prior quarters were below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) with sub par sales revenues growth. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot; </em><br><hr>3/19/2015 12:37:43 PM - Perched at its 52-week high after a spurt of gains. Held its ground near prior highs and above its 50 DMA line since last noted with caution in the 2/10/15 mid-day report - <em>&quot;Reported <strong>+60%</strong> earnings on <strong>+36%</strong> sales revenues for the Dec &#39;14 quarter. Prior quarters were below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) with sub par sales revenues growth. Its annual earnings (<strong>A</strong> criteria) history has been strong.&quot; </em><br><hr>2/10/2015 12:52:00 PM - Perched at its 52-week high following a considerable 2/05/15 gap up and volume-driven gain. Reported <strong>+60%</strong> earnings on <strong>+36%</strong> sales revenues for the Dec &#39;14 quarter.  Prior quarters were below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) with sub par sales revenues growth. Its annual earnings (<strong>A</strong> criteria) history has been strong.<br><hr>7/9/2013 12:51:58 PM - Considerable volume-driven gain today challenging its 52-week high following an analyst&#39;s new &quot;Buy&quot; rating and news that it is acquiring Care Pharmaceuticals, an Australian OTC healthcare products firm. Prior mid-day reports cautioned <em>- &quot;No resistance remains due to overhead supply, however it is extended from any sound base pattern. Reported earnings <strong>+38%</strong> on <strong>+15%</strong> sales revenues for the Mar &#39;13 quarter, marking its <strong>5</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong, and consensus estimates are calling for FY &#39;14 earnings <strong>+7%</strong> and FY &#39;15 earnings <strong>+9%</strong>.&quot;</em><br><hr>5/29/2013 12:39:02 PM - Consolidating in a tight range following a &quot;negative reversal&quot; on 5/16/13 after hitting a new 52-week high. Prior mid-day reports cautioned <em>- &quot;No resistance remains due to overhead supply, however it is extended from any sound base pattern. Reported earnings <strong>+38%</strong> on <strong>+15%</strong> sales revenues for the Mar &#39;13 quarter, marking its <strong>5</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong, and consensus estimates are calling for FY &#39;14 earnings <strong>+7%</strong> and FY &#39;15 earnings <strong>+9%</strong>.&quot;</em><br><hr>5/24/2013 12:51:36 PM - Retreating from its 52-week high following a &quot;negative reversal&quot; last week.  No resistance remains due to overhead supply, however it is extended from any sound base pattern. Reported earnings <strong>+38%</strong> on <strong>+15%</strong> sales revenues for the Mar &#39;13 quarter, marking its <strong>5</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong, and consensus estimates are calling for FY &#39;14 earnings <strong>+7%</strong> and FY &#39;15 earnings <strong>+9%</strong>.<br><hr>5/16/2013 12:45:24 PM - Gapped down today, retreating from a new 52-week high hit on the prior session before a &quot;negative reversal&quot; and lower close. No resistance remains due to overhead supply, however it is extended from any sound base pattern. Reported earnings <strong>+38%</strong> on <strong>+15%</strong> sales revenues for the Mar &#39;13 quarter, marking its <strong>5</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong, and consensus estimates are only calling for FY &#39;14 earnings <strong>+7%</strong> and FY &#39;15 earnings <strong>+5%</strong>.<br><hr>5/3/2013 1:18:53 PM - Hitting another new 52-week high with above average volume behind today&#39;s <strong>2</strong>nd consecutive gain. No resistance remains due to overhead supply. Held its ground stubbornly and made gradual progress since last noted in the 2/07/13 mid-day report with caution - <em>&quot;Reported earnings <strong>+48%</strong> on <strong>+51%</strong> sales revenues for the Dec &#39;12 quarter, marking its <strong>4</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong.&quot; </em><br><hr>2/7/2013 1:18:07 PM - Gapped up today and hit a new 52-week high, and no resistance remains due to overhead supply. Reported earnings <strong>+48%</strong> on <strong>+51%</strong> sales revenues for the Dec &#39;12 quarter, marking its <strong>4</strong>th consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong. Found support near its 50 DMA line while consolidating since last noted with caution in the 11/13/12 mid-day report following a considerable gap up and volume-driven rally for a new 52-week high.<em>&nbsp;</em><br><hr>11/13/2012 12:42:15 PM - No resistance remains due to overhead supply. Quietly consolidating since last noted in the 11/02/12 mid-day report following a considerable gap up and volume-driven rally for a new 52-week high - <em>&quot;Reported earnings <strong>+62%</strong> on <strong>+53%</strong> sales revenues for the Sep &#39;12 quarter, marking its <strong>3</strong>rd consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong.&quot; </em><br><hr>11/2/2012 12:43:22 PM - Edging higher today following a considerable gap up and volume-driven rally for a new 52-week high on the prior session, rising with no resistance remaining due to overhead supply. Reported earnings <strong>+62%</strong> on <strong>+53%</strong> sales revenues for the Sep &#39;12 quarter, marking its <strong>3</strong>rd consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong.<br><hr>11/1/2012 1:06:00 PM - Gapped up today and rallied for a new 52-week high, and no resistance remains due to overhead supply. Reported earnings <strong>+62%</strong> on <strong>+53%</strong> sales revenues for the Sep &#39;12 quarter, marking its <strong>3</strong>rd consecutive quarter with earnings above the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria) following <strong>3</strong> sub par quarterly comparisons. Its annual earnings (<strong>A</strong> criteria) history has not been especially strong.<br><hr>